Integrated BioPharma, Inc.
OTCPKIntegrated BioPharma heads into the week with a share price of $0.265 and an ownership structure so concentrated that conventional short-side pressure is almost irrelevant. The ownership picture is the defining feature here. Damon DeSantis holds 41.6% of the company outright, a position reported as recently as April 15. The DeSantis family and affiliated estates collectively…
Snapshot as of 10 May 2026
Integrated BioPharma heads into the week with a share price of $0.265 and an ownership structure so concentrated that conventional short-side pressure is almost irrelevant. The ownership picture is the defining feature…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INBP — free to start on ORTEX.
Sign up for free →Open INBP on ORTEX